The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective, innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-10-16", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "175795"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-16T11:01:56.86Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pharmaceutical Price Regulation Scheme"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the next Pharmaceutical Price Regulation Scheme considers combination treatments for cancer to be cost-effective.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"} } , "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"} , "tablingMemberPrinted" : [{"_value" : "Tom Brake"} ], "uin" : "175794"} , {"_about" : "http://data.parliament.uk/resources/982464", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982464/answer", "answerText" : {"_value" : "
The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective, innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-10-16", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "175794"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-16T11:01:56.923Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Pharmaceutical Price Regulation Scheme"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, when the heads of agreement for the next Pharmaceutical Price Regulation Scheme will be published.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"} } , "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"} , "tablingMemberPrinted" : [{"_value" : "Tom Brake"} ], "uin" : "175795"} , {"_about" : "http://data.parliament.uk/resources/982478", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982478/answer", "answerText" : {"_value" : "
It has been the policy of successive Governments not to comment on specific leaks and the Government takes such incidents very seriously. Leaks are investigated thoroughly and effectively, with established policies and procedures in place.<\/p>
<\/p>
Notwithstanding this, the Department continues to monitor and analyse overall staffing levels across the National Health Service, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high quality services on which patients rely following the United Kingdom\u2019s exit from the European Union. Our overall programme of work is comprehensive, thorough and continuously updated.<\/p>
<\/p>
Our plans include working with NHS and social care employers to ensure that the 167,000 EU nationals working across health and care are aware of the straightforward and user friendly EU settlement scheme which will allow them to secure long-term status in the UK and enjoy broadly the same rights and benefits as they do now.<\/p>
<\/p>
From the NHS Digital monthly Hospital and Community Health Service workforce statistics, as at June 2018, there are over 4,300 more EU27 nationals working in the NHS and clinical commissioning group\u2019s since the referendum.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"} } , "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"} , "answeringMemberPrinted" : {"_value" : "Stephen Barclay"} , "dateOfAnswer" : {"_value" : "2018-10-11", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "176070"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-11T16:06:48.597Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Staff"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the report, Leak reveals worst case scenario for nursing after Brexit, published by the Health Service Journal on 6 April 2017, what modelling his Department has conducted on the effect of the UK leaving the EU on NHS staffing levels.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1516", "label" : {"_value" : "Biography information for Andy Slaughter"} } , "tablingMemberConstituency" : {"_value" : "Hammersmith"} , "tablingMemberPrinted" : [{"_value" : "Andy Slaughter"} ], "uin" : "176069"} , {"_about" : "http://data.parliament.uk/resources/982479", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982479/answer", "answerText" : {"_value" : "
It has been the policy of successive Governments not to comment on specific leaks and the Government takes such incidents very seriously. Leaks are investigated thoroughly and effectively, with established policies and procedures in place.<\/p>
<\/p>
Notwithstanding this, the Department continues to monitor and analyse overall staffing levels across the National Health Service, and we are working across Government to ensure there will continue to be sufficient staff to deliver the high quality services on which patients rely following the United Kingdom\u2019s exit from the European Union. Our overall programme of work is comprehensive, thorough and continuously updated.<\/p>
<\/p>
Our plans include working with NHS and social care employers to ensure that the 167,000 EU nationals working across health and care are aware of the straightforward and user friendly EU settlement scheme which will allow them to secure long-term status in the UK and enjoy broadly the same rights and benefits as they do now.<\/p>
<\/p>
From the NHS Digital monthly Hospital and Community Health Service workforce statistics, as at June 2018, there are over 4,300 more EU27 nationals working in the NHS and clinical commissioning group\u2019s since the referendum.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"} } , "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"} , "answeringMemberPrinted" : {"_value" : "Stephen Barclay"} , "dateOfAnswer" : {"_value" : "2018-10-11", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "176069"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-11T16:06:48.66Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Nurses"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to the report, Leak reveals worst case scenario for nursing after Brexit, published by the Health Service Journal on 6 April 2017, whether (a) he and (b) other Ministers of his Department had sight of the modelling by his Department referenced in that report before that report was published.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1516", "label" : {"_value" : "Biography information for Andy Slaughter"} } , "tablingMemberConstituency" : {"_value" : "Hammersmith"} , "tablingMemberPrinted" : [{"_value" : "Andy Slaughter"} ], "uin" : "176070"} , {"_about" : "http://data.parliament.uk/resources/982490", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982490/answer", "answerText" : {"_value" : "
We understand that antipsychotic medications are vitally important to many people in this country. Our contingency plans include sensible mitigations for medicines that come to the United Kingdom from or via the European Union, such as precautionary stockpiling by suppliers, to ensure that the supply of antipsychotics and other essential medicines to patients is not disrupted.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4095", "label" : {"_value" : "Biography information for Steve Barclay"} } , "answeringMemberConstituency" : {"_value" : "North East Cambridgeshire"} , "answeringMemberPrinted" : {"_value" : "Stephen Barclay"} , "dateOfAnswer" : {"_value" : "2018-10-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-15T11:16:18.82Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Mental Illness: Prescription Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the UK maintains an adequate supply of antipsychotic medications in the event of the UK leaving the EU without a deal.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/151", "label" : {"_value" : "Biography information for Tom Brake"} } , "tablingMemberConstituency" : {"_value" : "Carshalton and Wallington"} , "tablingMemberPrinted" : [{"_value" : "Tom Brake"} ], "uin" : "175805"} , {"_about" : "http://data.parliament.uk/resources/982499", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982499/answer", "answerText" : {"_value" : "
HM Treasury has allocated over £2 billion of additional funding to departments and the devolved administrations for European Union exit preparations so far. This breaks down as:<\/p>
<\/p>
- £412 million of additional funding over the spending review period for the Department for Exiting the European Union, Department for International Trade and the Foreign and Commonwealth Office at Autumn Statement 2016.<\/p>
<\/p>
- £286 million of additional funding for 2017-18. A full breakdown of which can be found in Supplementary Estimates 2017-18 which is available at the following link:<\/p>
<\/p>
<\/p><\/td> | All pharmacotherapies<\/p><\/td> | Nicotine Replacement Therapies (NRT)<\/p><\/td> | Bupropion<\/p><\/td> | Varenicline<\/p><\/td><\/tr> | ||||||||||||||||||||
NIC (£000)<\/p><\/td> | <\/p><\/td> | <\/p><\/td> | <\/p><\/td><\/tr> | |||||||||||||||||||||
2015/16<\/p><\/td> | 33,218<\/p><\/td> | 15,672<\/p><\/td> | 814<\/p><\/td> | 16,732<\/p><\/td><\/tr> | ||||||||||||||||||||
2016/17<\/p><\/td> | 28,487<\/p><\/td> | 13,376<\/p><\/td> | 832<\/p><\/td> | 14,279<\/p><\/td><\/tr> | ||||||||||||||||||||
2017/18<\/p><\/td> | 26,017<\/p><\/td> | 12,038<\/p><\/td> | 889<\/p><\/td> | 13,090<\/p><\/td><\/tr><\/tbody><\/table> Source: NHS Digital published Statistics on NHS Stop Smoking Services in England - April 2017 to March 2018<\/p> <\/p> Notes:<\/p> 1. Prescriptions are written on a prescription form known as a FP10. Each single item written on the form is counted as a prescription item.<\/p> 2. The NIC of all pharmacotherapies is the basic cost of the treatments and does not take account of discounts, dispensing costs, fees or prescription charge income<\/p> 3. All pharmacotherapies includes NRT, bupropion (including branded medicine Zyban) and varenicline (including branded medicine Champix)<\/p> 4. This information was obtained from the Prescribing Analysis and CosT (PACT) system, which covers prescriptions prescribed by general practitioners, nurses, pharmacists and others in England and dispensed in the community in the United Kingdom. Prescriptions written in England but dispensed outside England are included. Prescriptions written in hospitals /clinics that are dispensed in the community, prescriptions dispensed in hospitals, dental prescribing and private prescriptions are not included in PACT data.<\/p> 5. Financial figures presented do not take into account inflation and are presented in cash terms only.<\/p> 6. Prescribing data presented in statistics on NHS Stop Smoking Services excludes data on drugs supplied direct to patients without prescriptions. Services such as Stop Smoking Services can supply NRT, either direct to patients or through vouchers redeemable at pharmacies. In addition, stop smoking prescription medications can be issued on behalf of these services by pharmacists through Patient Group Directions. These supplies are not recorded in national prescriptions datasets and are also excluded.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-10-17", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-17T16:33:24.09Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Smoking"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of smoking cessation treatments (a) varenicline, (b) bupropion and (c) nicotine replacement therapies in each of the last three years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "tablingMemberConstituency" : {"_value" : "North Norfolk"} , "tablingMemberPrinted" : [{"_value" : "Norman Lamb"} ], "uin" : "176020"} , {"_about" : "http://data.parliament.uk/resources/982522", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982522/answer", "answerText" : {"_value" : " The information requested is not held centrally.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-10-16", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-10-16T16:37:38.347Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2018-10-08", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Smoking"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many referrals (a) NHS acute trusts and (b) NHS mental health trusts made to smoking cessation services in each of the last three years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1439", "label" : {"_value" : "Biography information for Norman Lamb"} } , "tablingMemberConstituency" : {"_value" : "North Norfolk"} , "tablingMemberPrinted" : [{"_value" : "Norman Lamb"} ], "uin" : "176021"} , {"_about" : "http://data.parliament.uk/resources/982523", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/982523/answer", "answerText" : {"_value" : " NHS Digital reports that it does not hold the prescription level data requested. NHS Digital holds data about prescription items dispensed by doctors and community pharmacies in England which is available in the following table.<\/p> <\/p>
|